Summary:
Lenire, the FDA-approved bimodal neuromodulation device for tinnitus, is sponsoring the 10th Annual Hearoes Tour to expand access to hearing and tinnitus care for U.S. veterans through free nationwide screenings and support.
Key Takeaways:
- Lenire’s Partnership: Lenire’s sponsorship empowers the Hearoes Tour to connect veterans with a clinically validated tinnitus treatment.
- National Impact: The Hearoes Tour has hosted over 1,000 free hearing health events and conducted more than 33,000 screenings, directly addressing care accessibility across the U.S.
- Veteran-Focused Solution: With tinnitus as the #1 service-connected disability among veterans, Lenire’s availability through VA facilities can greatly benefit this patient population.
Lenire, an FDA-Approved tinnitus treatment, is sponsoring the 10th Annual LexCare Hearing Foundation Hearoes Tour to raise awareness of, and access to, hearing and tinnitus care options for U.S. Veterans.
The Hearoes Tour is a national movement that brings free hearing health resources, screenings, and guidance directly to veteran communities across America.
Hosting over 200 events annually, The Hearoes Tour removes accessibility barriers to hearing and tinnitus care by simplifying the process, addressing affordability concerns, raising awareness of untreated hearing loss side effects, and increasing access to care. To date, the Hearoes tour has conducted over 33,000 hearing screenings and hosted more than 1,000 free hearing health events.
“Nearly 40% of the veterans we’ve served through the Hearoes Tour have reported experiencing tinnitus and yet, for years, we had no real solution to offer them,” says Jaime Motes, founder/director, The LexCare Hearing Foundation.
“It’s personal for me—my daughter has cochlear implants because she was born deaf, continues Motes. “She has an answer. Every veteran deserves an answer, too. Now, we finally do. Thanks to our partnership with Lenire we are finally able to connect veterans with a real life-changing tinnitus treatment option after years of advocacy, awareness, and outreach.
“This partnership is a milestone in our mission to eliminate the barriers to hearing and tinnitus care. Together, we are providing real hope and real solutions for those who have sacrificed so much.”
Tinnitus: The #1 Service-Connected Disability
Tinnitus has been the number one service-connected disability compensated for by the VA since 1955. Veterans received an estimated $6.6 billion in service-connected compensation for tinnitus in 2024.1 And 63% of all auditory Veteran Compensation Claims were for tinnitus.1
Neuromod, the medical device company behind Lenire, was awarded a FSS 65 II Medical Equipment & Supply Contract, making Lenire a treatment option for 3.2 million U.S. Military veterans living with tinnitus through the Department of Veterans Affairs.1
Lenire is the first bimodal neuromodulation device for tinnitus to receive a Federal Supply Schedule (FSS) Contract. To date, 50 USVA facilities have been trained to provide treatment with Lenire with more scheduled for training in 2025.
“Sponsoring the 10th Annual Hearoes Tour, and supporting the invaluable services The Lexcare Hearing Foundation provides, advances our commitment to veterans by increasing awareness and accessibility of life-changing hearing and tinnitus care treatment options,” says Eric Timm, Neuromod USA CEO and Neuromod devices president of global commercial operations.
Reference
Featured image: Lenire
